Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ambulatory Surgical Procedures | 1 | 2015 | 103 | 0.470 |
Why?
|
| Blood Loss, Surgical | 3 | 2009 | 295 | 0.340 |
Why?
|
| Aprotinin | 1 | 2009 | 30 | 0.330 |
Why?
|
| Intubation, Intratracheal | 6 | 2014 | 469 | 0.320 |
Why?
|
| Hemostatics | 1 | 2009 | 82 | 0.310 |
Why?
|
| Pneumonectomy | 2 | 2009 | 862 | 0.280 |
Why?
|
| Pain, Postoperative | 3 | 2001 | 662 | 0.270 |
Why?
|
| Laryngeal Masks | 2 | 2022 | 78 | 0.270 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 485 | 0.230 |
Why?
|
| Mesothelioma | 1 | 2009 | 558 | 0.220 |
Why?
|
| Anesthesia | 3 | 1993 | 301 | 0.220 |
Why?
|
| Methemoglobinemia | 1 | 2003 | 17 | 0.220 |
Why?
|
| Anesthesia, Closed-Circuit | 2 | 1997 | 4 | 0.210 |
Why?
|
| Pulmonary Atelectasis | 1 | 2022 | 51 | 0.200 |
Why?
|
| Anesthetics | 1 | 2003 | 118 | 0.200 |
Why?
|
| Posture | 1 | 2002 | 190 | 0.200 |
Why?
|
| Fracture Fixation | 1 | 2001 | 34 | 0.190 |
Why?
|
| Ankle Injuries | 1 | 2001 | 37 | 0.190 |
Why?
|
| Ketorolac | 1 | 2001 | 23 | 0.190 |
Why?
|
| Analgesia, Epidural | 1 | 2001 | 101 | 0.180 |
Why?
|
| Morphine | 2 | 2001 | 331 | 0.170 |
Why?
|
| Fasciculation | 1 | 1998 | 1 | 0.160 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1998 | 7 | 0.160 |
Why?
|
| Succinylcholine | 1 | 1998 | 6 | 0.160 |
Why?
|
| Oximetry | 4 | 1994 | 190 | 0.160 |
Why?
|
| Torsades de Pointes | 1 | 1998 | 11 | 0.160 |
Why?
|
| Oxygen | 4 | 1994 | 791 | 0.160 |
Why?
|
| Methyl Ethers | 1 | 1998 | 29 | 0.160 |
Why?
|
| Analgesics | 1 | 2001 | 408 | 0.150 |
Why?
|
| Anesthetics, Inhalation | 1 | 1998 | 65 | 0.150 |
Why?
|
| Carbon Dioxide | 2 | 1996 | 328 | 0.150 |
Why?
|
| Analgesics, Opioid | 2 | 2014 | 1468 | 0.150 |
Why?
|
| Ketamine | 1 | 2001 | 238 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 540 | 0.140 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2007 | 17 | 0.140 |
Why?
|
| Ondansetron | 1 | 2007 | 39 | 0.140 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2007 | 43 | 0.140 |
Why?
|
| Laryngoscopes | 1 | 1998 | 84 | 0.140 |
Why?
|
| Vagus Nerve | 1 | 1996 | 70 | 0.130 |
Why?
|
| Bradycardia | 1 | 1996 | 73 | 0.130 |
Why?
|
| Fentanyl | 2 | 2014 | 153 | 0.130 |
Why?
|
| Respiration | 3 | 1994 | 465 | 0.130 |
Why?
|
| Morpholines | 1 | 2007 | 296 | 0.130 |
Why?
|
| Recovery Room | 1 | 1994 | 5 | 0.120 |
Why?
|
| Postanesthesia Nursing | 1 | 1994 | 5 | 0.120 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1994 | 48 | 0.120 |
Why?
|
| Video Recording | 1 | 2014 | 281 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2014 | 39890 | 0.100 |
Why?
|
| Sleep | 1 | 1994 | 442 | 0.090 |
Why?
|
| Double-Blind Method | 5 | 2009 | 2580 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 585 | 0.090 |
Why?
|
| Humans | 37 | 2022 | 270740 | 0.090 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2014 | 259 | 0.090 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 2 | 2001 | 12 | 0.090 |
Why?
|
| Thoracic Surgery | 1 | 1994 | 284 | 0.090 |
Why?
|
| Hernia, Hiatal | 1 | 1990 | 67 | 0.090 |
Why?
|
| Equipment Failure | 3 | 1998 | 191 | 0.080 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1990 | 124 | 0.080 |
Why?
|
| Postoperative Complications | 4 | 2003 | 5681 | 0.080 |
Why?
|
| Sleep Apnea Syndromes | 3 | 1998 | 87 | 0.080 |
Why?
|
| Cardiac Tamponade | 1 | 1989 | 49 | 0.080 |
Why?
|
| Anesthesia, General | 2 | 2022 | 222 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 1992 | 521 | 0.080 |
Why?
|
| Anesthesia, Intravenous | 1 | 2007 | 39 | 0.070 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2001 | 63 | 0.070 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 2002 | 9 | 0.070 |
Why?
|
| Aortic Aneurysm | 1 | 1989 | 218 | 0.070 |
Why?
|
| Pancuronium | 2 | 2001 | 12 | 0.070 |
Why?
|
| Anesthesia, Inhalation | 2 | 1999 | 29 | 0.070 |
Why?
|
| Postoperative Care | 2 | 2009 | 728 | 0.070 |
Why?
|
| Research Design | 2 | 2009 | 1569 | 0.060 |
Why?
|
| Equipment Design | 3 | 2014 | 1197 | 0.060 |
Why?
|
| United States Food and Drug Administration | 1 | 1997 | 323 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 424 | 0.060 |
Why?
|
| Tranexamic Acid | 2 | 1995 | 23 | 0.060 |
Why?
|
| Male | 14 | 2015 | 128315 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2007 | 689 | 0.060 |
Why?
|
| Rosaniline Dyes | 1 | 2004 | 109 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 1 | 1984 | 45 | 0.060 |
Why?
|
| Time Factors | 6 | 2009 | 13006 | 0.060 |
Why?
|
| Female | 17 | 2015 | 148940 | 0.060 |
Why?
|
| Middle Aged | 15 | 2014 | 90352 | 0.060 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2003 | 14 | 0.060 |
Why?
|
| Obstetric Labor Complications | 1 | 1984 | 99 | 0.050 |
Why?
|
| Plethysmography | 2 | 1994 | 38 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2001 | 591 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 275 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 2 | 1995 | 391 | 0.050 |
Why?
|
| Blood Coagulation Disorders | 1 | 2003 | 115 | 0.050 |
Why?
|
| Positive-Pressure Respiration | 1 | 2022 | 123 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 264 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 1994 | 131 | 0.050 |
Why?
|
| Naloxone | 1 | 2001 | 106 | 0.050 |
Why?
|
| Anesthesia, Conduction | 1 | 2001 | 44 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2001 | 155 | 0.040 |
Why?
|
| Laryngoscopy | 1 | 2002 | 199 | 0.040 |
Why?
|
| Muscle Weakness | 1 | 2001 | 111 | 0.040 |
Why?
|
| Intraoperative Period | 2 | 2014 | 251 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 4963 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2003 | 437 | 0.040 |
Why?
|
| Androstanols | 1 | 1998 | 4 | 0.040 |
Why?
|
| Adult | 14 | 2007 | 82040 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2003 | 600 | 0.040 |
Why?
|
| Hypoxia | 2 | 1991 | 472 | 0.040 |
Why?
|
| Wakefulness | 2 | 1999 | 156 | 0.040 |
Why?
|
| Bronchoscopy | 2 | 2014 | 481 | 0.040 |
Why?
|
| Survival Rate | 2 | 2009 | 12541 | 0.040 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2007 | 30 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 9039 | 0.040 |
Why?
|
| Aged | 7 | 2014 | 73333 | 0.040 |
Why?
|
| Anesthesiology | 1 | 1999 | 146 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2007 | 3077 | 0.030 |
Why?
|
| Absorption | 1 | 1996 | 74 | 0.030 |
Why?
|
| Airway Resistance | 1 | 1996 | 43 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 1996 | 48 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 1996 | 47 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5574 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 1998 | 213 | 0.030 |
Why?
|
| Pressure | 1 | 1996 | 178 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2009 | 13414 | 0.030 |
Why?
|
| Data Collection | 2 | 1999 | 608 | 0.030 |
Why?
|
| Tidal Volume | 1 | 1994 | 58 | 0.030 |
Why?
|
| Nitrous Oxide | 1 | 1994 | 18 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1994 | 9 | 0.030 |
Why?
|
| Anesthesia Recovery Period | 2 | 1991 | 33 | 0.030 |
Why?
|
| Aminocaproic Acid | 1 | 1993 | 17 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 1994 | 99 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2014 | 146 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 5315 | 0.030 |
Why?
|
| Bias | 1 | 1993 | 216 | 0.020 |
Why?
|
| Canada | 1 | 1993 | 440 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1994 | 512 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 12033 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 1993 | 558 | 0.020 |
Why?
|
| Lung | 1 | 2022 | 3298 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 1993 | 521 | 0.020 |
Why?
|
| Body Weight | 1 | 1994 | 1307 | 0.020 |
Why?
|
| Analysis of Variance | 3 | 2003 | 2315 | 0.020 |
Why?
|
| Blood Coagulation | 2 | 2003 | 168 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 6177 | 0.020 |
Why?
|
| Preoperative Care | 1 | 1994 | 1567 | 0.020 |
Why?
|
| Phenytoin | 1 | 1988 | 81 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1990 | 666 | 0.020 |
Why?
|
| Video-Assisted Surgery | 1 | 2007 | 30 | 0.020 |
Why?
|
| Intraoperative Care | 2 | 2003 | 274 | 0.020 |
Why?
|
| Risk Factors | 4 | 2004 | 17888 | 0.020 |
Why?
|
| Adolescent | 4 | 2007 | 32767 | 0.020 |
Why?
|
| Mediastinum | 1 | 2007 | 276 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 5056 | 0.020 |
Why?
|
| Blood Transfusion | 2 | 2003 | 581 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 5101 | 0.020 |
Why?
|
| Smoking | 1 | 1994 | 2555 | 0.020 |
Why?
|
| Age Factors | 1 | 1994 | 5457 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 1997 | 361 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 1989 | 534 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6256 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2007 | 30998 | 0.010 |
Why?
|
| Injections | 1 | 2004 | 286 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2003 | 59 | 0.010 |
Why?
|
| Transfusion Reaction | 1 | 2003 | 101 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 2 | 1995 | 206 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 10265 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 886 | 0.010 |
Why?
|
| Tourniquets | 1 | 2001 | 15 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1984 | 402 | 0.010 |
Why?
|
| Child | 2 | 2004 | 30559 | 0.010 |
Why?
|
| Random Allocation | 1 | 1999 | 741 | 0.010 |
Why?
|
| Disease Management | 1 | 2003 | 1090 | 0.010 |
Why?
|
| Pregnancy | 2 | 1994 | 8130 | 0.010 |
Why?
|
| United States | 2 | 1999 | 15861 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1995 | 82 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 4878 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1994 | 141 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 5162 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 4960 | 0.010 |
Why?
|
| Perioperative Care | 1 | 1998 | 447 | 0.010 |
Why?
|
| Self Administration | 1 | 1994 | 58 | 0.010 |
Why?
|
| Analgesia | 1 | 1994 | 97 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1993 | 47 | 0.010 |
Why?
|
| Premedication | 1 | 1993 | 133 | 0.010 |
Why?
|
| Societies, Medical | 1 | 1999 | 1320 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 1993 | 110 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 1312 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 1437 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 14012 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 1991 | 27 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 5051 | 0.010 |
Why?
|
| Consciousness | 1 | 1991 | 55 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1993 | 482 | 0.010 |
Why?
|
| Heparin | 1 | 1993 | 342 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1994 | 654 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1993 | 530 | 0.010 |
Why?
|
| Pain Measurement | 1 | 1994 | 1016 | 0.010 |
Why?
|
| Preanesthetic Medication | 1 | 1988 | 9 | 0.000 |
Why?
|
| Diazepam | 1 | 1988 | 40 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1988 | 107 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2004 | 17061 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1999 | 5923 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1988 | 572 | 0.000 |
Why?
|
| Animals | 1 | 2003 | 61956 | 0.000 |
Why?
|